110 related articles for article (PubMed ID: 7292509)
21. Effect of purine and pyrimidine analogues on reversion of a tryptophan-requiring strain of Escherichia coli.
DOUDNEY CO; HAAS FL
Nature; 1959 Jul; 184():114-5. PubMed ID: 13817798
[No Abstract] [Full Text] [Related]
22. Inhibition of uricase by pyrimidine and purine drugs.
Hurst DT; Griffiths E; Vayianos C
Clin Biochem; 1985 Aug; 18(4):247-51. PubMed ID: 4042322
[TBL] [Abstract][Full Text] [Related]
23. INTERACTION OF PURINES WITH THE PYRIMIDINE TRANSPORT PROCESS OF THE SMALL INTESTINE.
SCHANKER LS; JEFFREY JJ; TOCCO DJ
Biochem Pharmacol; 1963 Sep; 12():1047-53. PubMed ID: 14068500
[No Abstract] [Full Text] [Related]
24. Purine metabolism and differential inhibition of spore germination in Phytophthora infestans.
Clark MC; Melanson DL; Page OT
Can J Microbiol; 1978 Sep; 24(9):1032-8. PubMed ID: 709431
[TBL] [Abstract][Full Text] [Related]
25. Antimycobacterial agents. 1. Thio analogues of purine.
Pathak AK; Pathak V; Seitz LE; Suling WJ; Reynolds RC
J Med Chem; 2004 Jan; 47(1):273-6. PubMed ID: 14695841
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis and anticancer activity of fluorocyclopentenyl-purines and - pyrimidines.
Yoon JS; Jarhad DB; Kim G; Nayak A; Zhao LX; Yu J; Kim HR; Lee JY; Mulamoottil VA; Chandra G; Byun WS; Lee SK; Kim YC; Jeong LS
Eur J Med Chem; 2018 Jul; 155():406-417. PubMed ID: 29906687
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of nonclassical 2,4-diamino-5-methylpyrido[2,3-d]pyrimidines with novel side chain substituents as potential inhibitors of dihydrofolate reductases.
Gangjee A; Vasudevan A; Queener SF
J Med Chem; 1997 Feb; 40(4):479-85. PubMed ID: 9046338
[TBL] [Abstract][Full Text] [Related]
28. Purine and pyrimidine inhibitors of arginase.
Rosenfeld JL; Dutta SP; Chheda GB; Tritsch GL
Biochim Biophys Acta; 1975 Nov; 410(1):164-6. PubMed ID: 1238117
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of methotrexate resistant mutant of Streptococcus faecalis by analogs of purine and pyrimidine.
Doctor VM
Chemotherapy; 1970; 15(1):52-8. PubMed ID: 4985487
[No Abstract] [Full Text] [Related]
30. Inhibition of Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium dihydrofolate reductases by 2,4-diamino-5-[2-methoxy-5-(omega-carboxyalkyloxy)benzyl]pyrimidines: marked improvement in potency relative to trimethoprim and species selectivity relative to piritrexim.
Rosowsky A; Forsch RA; Queener SF
J Med Chem; 2002 Jan; 45(1):233-41. PubMed ID: 11754594
[TBL] [Abstract][Full Text] [Related]
31. Dual inhibitors of thymidylate synthase and dihydrofolate reductase as antitumor agents: design, synthesis, and biological evaluation of classical and nonclassical pyrrolo[2,3-d]pyrimidine antifolates(1).
Gangjee A; Jain HD; Phan J; Lin X; Song X; McGuire JJ; Kisliuk RL
J Med Chem; 2006 Feb; 49(3):1055-65. PubMed ID: 16451071
[TBL] [Abstract][Full Text] [Related]
32. THE MECHANISM OF ACTION OF PURINE AND PYRIMIDINE ANALOGS IN MICROORGANISMS.
KEMPNER ES; MILLER JH
Biochim Biophys Acta; 1963 Nov; 76():341-6. PubMed ID: 14097396
[No Abstract] [Full Text] [Related]
33. BIOCHEMISTRY OF CANCER (METABOLIC ASPECTS).
BROCKMAN RW; ANDERSON EP
Annu Rev Biochem; 1963; 32():463-512. PubMed ID: 14144487
[No Abstract] [Full Text] [Related]
34. Inhibition by pyrimidine analogues of the synthesis of folic acid by trachoma agents.
Reeve P; Taverne J; Bushby SR
J Hyg (Lond); 1968 Jun; 66(2):295-306. PubMed ID: 5304542
[No Abstract] [Full Text] [Related]
35. Effects of some analogues of purines, pyrimidines and ammo-acids on the early development ofPlanorbis exustus.
Diwan BA
Wilhelm Roux Arch Entwickl Mech Org; 1968 Mar; 160(1):112-118. PubMed ID: 28304495
[TBL] [Abstract][Full Text] [Related]
36. New 2,4-diamino-5-(2',5'-substituted benzyl)pyrimidines as potential drugs against opportunistic infections of AIDS and other immune disorders. Synthesis and species-dependent antifolate activity.
Rosowsky A; Forsch RA; Sibley CH; Inderlied CB; Queener SF
J Med Chem; 2004 Mar; 47(6):1475-86. PubMed ID: 14998335
[TBL] [Abstract][Full Text] [Related]
37. L-beta-(2S,4S)- and L-alpha-(2S,4R)-dioxolanyl nucleosides as potential anti-HIV agents: asymmetric synthesis and structure-activity relationships.
Kim HO; Schinazi RF; Shanmuganathan K; Jeong LS; Beach JW; Nampalli S; Cannon DL; Chu CK
J Med Chem; 1993 Mar; 36(5):519-28. PubMed ID: 8496934
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, antifolate, and antitumor activities of classical and nonclassical 2-amino-4-oxo-5-substituted-pyrrolo[2,3-d]pyrimidines.
Gangjee A; Vidwans A; Elzein E; McGuire JJ; Queener SF; Kisliuk RL
J Med Chem; 2001 Jun; 44(12):1993-2003. PubMed ID: 11384244
[TBL] [Abstract][Full Text] [Related]
39. Selective Pneumocystis carinii dihydrofolate reductase inhibitors: design, synthesis, and biological evaluation of new 2,4-diamino-5-substituted-furo[2,3-d]pyrimidines.
Gangjee A; Guo X; Queener SF; Cody V; Galitsky N; Luft JR; Pangborn W
J Med Chem; 1998 Apr; 41(8):1263-71. PubMed ID: 9548816
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and biological activities of tricyclic conformationally restricted tetrahydropyrido annulated furo[2,3-d]pyrimidines as inhibitors of dihydrofolate reductases.
Gangjee A; Elzein E; Queener SF; McGuire JJ
J Med Chem; 1998 Apr; 41(9):1409-16. PubMed ID: 9554874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
